2013 Participating Companies

  • Recommend
  • Tweet
  • Print
  • Email
Below are the 2013 participating companies. To see the list of 2012 participating companies, click here.
 

4P Therapeutics
5AM Ventures
Accele Biopharma, Inc.
Achaogen, Inc.
ADM Diagnostics, LLC
Affimed Therapeutics AG
Akron Molecules GmbH
Alethia Biotherapeutics Inc.
Alios Biopharma, Inc.
Alta Partners
Altheus Therapeutics, Inc.
Altravax, Inc.
Ambit Biosciences
Ambrx Inc.
America Stem Cell Inc.
Amgen Inc.
AM-Pharma B.V.
Angiochem
Anthrocell Pty
Apposite Capital
Aquilo Capital
Aquinox Pharmaceuticals, Inc.
Armour Therapeutics Inc
Ash Stevens Inc.
Astellas Pharma Inc.
Astex Pharmaceuticals, Inc.
AstraZeneca
Asuragen, Inc.
Asymmetry Global Healthcare
ATEL Ventures
Athyrium Capital Management
Atossa Genetics, Inc.
Auspex Pharmaceuticals, Inc
AvidBiotics Corp.
BASF Venture Capital
Bavarian Nordic, A/S
Baxter International Inc
Baxter Ventures
Bay City Capital
BayBio
BDC Capital Healthcare Fund
BEAT Biotherapeutics Corp.
Bellicum Pharmaceuticals, Inc.
Bijan Capital
BioCrea
Biodesy LLC
BioMed Ventures
BiomedTracker
Bio-Path Holdings, Inc.
BioWorld Today
Blaise Group International
Boehringer Ingelheim Pharmaceutical, Inc
Breakout Labs/ Thiel Foundation
Bristol-Myers Squibb
Burrage Capital
Burrill & Company
Business Development Bank of Canada
Business Wire
BVF L.P.
BWS Financial Inc.
CanaccordGenuity
Capital Royalty L.P.
Catalyst Pharmaceutical Partners
Cato BioVentures
Cerecor Inc.
CertiChem, Inc
CG Pharmaceuticals, Inc
Chubb Group of Insurance Companies
Cipher Pharmaceuticals Inc.
Clinical Persona, Inc.
Colo. Inst. for Drug Device & Diag. Dev.
Conatus Pharmaceuticals
Confluence Life Sciences, Inc
Consulate General of Canada
Contrafect
Corium International, Inc
Coyote Pharmaceuticals
Critical Outcome Technologies Inc.
Cureduchenne
Cyclica Therapeutics Inc
CytomX Therapeutics, Inc.
Dalton Pharma Services
Danken Ventures
Dectiva
Dentons
diaDexus, Inc.
DiaMedica
Dicerna Pharmaceuticals
Dillon Capital Strategies
DiscoveryBioMed, Inc
Dorset Capital LLC
EBD Group
EcoR1 Capital, LLC
Edison Investment Research
EGEN, Inc
EicOsis, LLC
ELEISON PHARMACEUTICALS LLC
Eli Lilly and Company
Elsevier Business Intelligence
Elusys Therapeutics
Enso Ventures
Epirus Biopharmaceuticals, Inc.
EPISTAT
Esperion Therapuetics, Inc.
Evotec International GmbH
Fate Therapeutics, Inc.
Fenwick & West LLP
Five Prime Therapeutics
Forest Laboratories, Inc.
FORMA Therapeutics
Four Oaks Partners
FPRT Bio
Franklin Templeton Investments
Frazier Healthcare Ventures
GE capital
Gemmus Pharma Inc.
GeneCentric Diagnostics, Inc
Genenews
GenSpera, Inc.
Georgia State University Research Foundation
GlobeImmune, Inc.
GLYCOMIMETICS, INC.
Greenwich LifeSciences
Halsa Pharmaceuticals
Healthy Living Magazine
Heat Biologics
Helix Ventures
HepSeeVax
Hightech Reports
Horizon Pharma
Hua Medicine
Igenica, Inc
immatics biotechnologies GmbH
Immune Design
IMMUNE Pharmaceuticals Inc
Immunovaccine
INanoBio
Innotrove LLC
Innovus Pharmaceuticals, Inc.
inovation ventures
Inovio Pharmaceuticals
InSymbiosis
Integrium
International Finance Corporation
International Stem Cell Corporation
Inventis Investment Holdings (China) Ltd
Investor Growth Capital
IPF Partners
Jade Therapeutics, Inc.
Janssen Pharmaceutical Companies of John
Jennerex, Inc.
Johnson & Johnson
JT Pharma
Kala Pharmaceuticals
KangLaiTe USA Inc
Karolinska Development AB (publ.)
Kearny Venture Partners
KineMed, Inc
Kissei America, Inc
KMA & Company
Knobbe Martens Olson & Bear LLP
Knoll Capital Management LLC
KPCB
KVP
La Jolla Pharmaceutical Company
Labrys Biologics, Inc.
Latterell Venture Partners
Leading Biosciences, Inc.
Life Science Angels
Life Science Leader
Lion Biotechnologies
Livwel Therapeutics Inc
Longitude Captial
Lumira Capital
MabVax Therapeutics, Inc.
Mast Therapeutics, Inc.
Maverix Biomics, Inc.
MAX BioPharma Inc.
MaxCyte
Medical Technology Stock Letter
MedPanel Capital Advisors
Menogenix, Inc.
Mercadyne Investments, LLC
Merck
Mercury Fund
Mergermarket
Microbiotix, Inc.
Milestone Capital
Mirna Therapeutics, Inc
Mission Bay Capital
Mitsubishi Corporation
Mizuho Securities USA
Mochida Pharmaceutical
Momenta Pharmaceuticals, Inc.
Morgan Lewis & Bockius LLP
Morphochem AG
MP Healthcare Venture Management, Inc.
MPM Capital
Muse Capital
MustangVC
MyeloRx LLC
Nano3D Biosciences, Inc.
Nanofiber Solutions
NEA
NeoStem
Neuraltus Pharmaceuticals, Inc.
New Biology Ventures, LLC
New Enterprise Associates
NEWGEN THERAPEUTICS, INC.
Next Big Thing Investor.com
NGN Capital LLC
NLV
NLVP
NOVARTIS
Novartis Venture Fund
NovelMed Therapeutics, Inc.
Numab AG
Numoda Capital Innovations
Ocera Therapeutics, Inc
OncologyLink news-n-notes
OncoMed Pharmaceuticals, Inc.
OncoSec Medical
Ontario Government
Onyx Pharmaceuticals
Opsona Therapeutics Ltd.
Opus Point Partners
Orange County Research Center
OrbiMed Advisors
Oxford Bioscience Partners
Oxigene
OxThera AB
Palatin Technologies, Inc.
Palo Alto Investors
Parabon NanoLabs
ParinGenix, Inc.
Patrys Limited
Piper Jaffray & Co
Poliwogg
Polynoma
PreScience Labs
Principia Biopharma
Probiodrug AG
Protagonist Therapeutics Inc.
Proteon Therapeutics, Inc.
Purdue Pharma LP
Quest PharmaTech Inc
Questcor Pharmaceuticals, Inc
QVT
Radius Health, Inc
RECARDIO
Regado Biosciences, Inc.
Resverlogix
ROTH Capital Partners
Russo Partners
RXi Pharmaceuticals
S1 Biopharma
S1 Biopharma, Inc.
Sagient Research
San Diego Tech Coast Angels
San Francisco Business Times
SantA Ventures
ScarX Therapeutics
scendiant
Science Futures
Scrip Intelligence
Sensorion
Sernova Corp
Shinyusha Publishing
Sialix
Sirona Biochem
SironRX Therapeutics, Inc.
Slater Technology Fund
Sofinnova Ventures
Sophiris Bio, Corp
Spring Bank Pharmaceuticals
SR One, Limited
Stemina Biomarker Discovery
Stiftelsen Industrifonden
Strategy Signal LLC
Sutro Biopharma, Inc
SVB
Syndax Pharmaceuticals, Inc.
Syzygy Therapeutics
Tavistock Group
Tech Coast Angels
TeraDiscoveries, Inc
The Burrill Report
The Conafay Group
The Life Sciences Report
The Scripps Research Institute
The Trout Group LLC
Theraclone Sciences, Inc
TherapeuticsMD.com
TheraVasc Inc.
Third Rock Ventures
Thorner Ventures
three arch
TissueGene, Inc.
Topica Pharmaceuticals, Inc.
TriplePoint Capital
Tymora Analytical Operations
Tynan Consulting
UCSF
US Venture Partners
Vaccinex
Valence Life Sciences
Vascular Pharmaceuticals
Versant Ventures
Versartis, Inc.
viDA Therapeutics Inc
Viking Therapeutics, Inc.
Visionary Pharmaceuticals
Vista Partners LLC
Vivaldi Biosciences Inc.
Vivo Ventures
VWR International, LLC
Wall Street Journal
WCG
William Harris Investors
WRF Capital
www.carmot.us
Xalud Therapeutics, Inc.
Zafgen
ZIOPHARM Oncology, Inc
Zymeworks Inc.
 
*Updated 9/30/2013